Corcept Therapeutics Incorporated’s CORT share price has dipped by 19.51%, which has investors questioning if this is right time to buy.

The ROSELLA study evaluating Corcept's relacorilant plus nab-paclitaxel for treating patients with platinum-resistant ovarian ...

Pune: A 45-year-old woman from Satara recently underwent a dual procedure in the city to treat two rare conditions: a recurring tumour of the abdomina.

Robotic surgery is known for its precision, as well as its ability to reduce pain, bleeding, and recovery time for patients.

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study ...

Pre- Sons of Anarchy and Billions, Maggie Siff showed up in the season 4 episode "The Heart of the Matter" in 2007. Siff ...

Advanced lung cancer, which has spread (metastasized) from the primary tumor to distant organs, is associated with lower survival rates. That's because lung cancer becomes more difficult to treat as ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...